Aspire Biopharma Holdings, Inc. Warrant (ASBPW)
Market Closed
8 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 01
0
0%
Pre Market
$
+0 +0.7519% 0. 01
226.59K Market Cap
- P/E Ratio
- Div Yield
10,395 Volume
- Eps
$ 0.01
Previous Close Want to track ASBPW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
ASBPW closed Tuesday higher at $0.01, an increase of 0% from Monday's close, completing a monthly decrease of -69.5652% or -$0.03. Over the past 12 months, ASBPW stock lost -33.5%.
ASBPW is not paying dividends to its shareholders.
Aspire Biopharma Holdings, Inc. Warrant has completed 1 stock splits, with the recent split occurring on May 11, 2026.
The company's stock is traded on one exchange.
Aspire Biopharma Holdings, Inc. Warrant Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| VL Vincent Leva Linden Advisors LP | 899,999 | $80,090.91 | $16,469.98 | -$63,620.93 | -79.44% |
| BO Brian Oliveira Clear Street Group Inc. | 330,664 | $16,920.74 | $4,397.83 | -$12,522.91 | -74.01% |
 Mikhail Shilshtut Limestone Investment Advisors LP | 75,000 | $4,949.17 | $982.5 | -$3,966.67 | -80.15% |
Aspire Biopharma Holdings, Inc. Warrant (ASBPW) FAQ
What is the stock price today?
The current price is $0.01.
On which exchange is it traded?
Aspire Biopharma Holdings, Inc. Warrant is listed on NASDAQ (CM).
What is its stock symbol?
The ticker symbol is ASBPW.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 226.59K.
Has Aspire Biopharma Holdings, Inc. Warrant ever had a stock split?
Aspire Biopharma Holdings, Inc. Warrant had 1 splits and the recent split was on May 11, 2026.
Aspire Biopharma Holdings, Inc. Warrant Profile
| Biotechnology Industry | Healthcare Sector | Kraig T. Higginson CEO | NASDAQ (CM) Exchange | 738920115 CUSIP |
| US Country | 2 Employees | - Last Dividend | 11 May 2026 Last Split | - IPO Date |
Overview
Aspire Biopharma Holdings, Inc. is an innovative early-stage biopharmaceutical company based in Estero, Florida. Founded in 2021, the company focuses on the development and commercialization of groundbreaking sublingual delivery mechanisms within the United States. This novel approach is designed to enhance the absorption and efficacy of various medications, particularly in urgent medical scenarios such as cardiology emergencies and pain management.
Products and Services
- Instaprin:
Instaprin is a sublingual aspirin product that boasts a soluble, pH neutral, and fast-acting formulation. It is specifically designed to address cardiology emergencies and facilitate effective pain management by allowing rapid entry into the bloodstream. - Melatonin Sleep-Aid Product:
This formulation aims to provide a convenient and efficient method of sleep support. Administered sublingually, it is designed to promote relaxation and restorative sleep by allowing quick absorption into the system. - Vitamins D, E, and K:
These essential vitamins are being formulated for sublingual administration, allowing for improved bioavailability and quicker uptake into the body compared to traditional oral methods. - Testosterone Products:
Aspire is working on sublingual formulations for testosterone, potentially offering men a more effective alternative to traditional testosterone delivery methods for hormonal balance. - Semaglutide Product:
The company is in the process of developing a sublingual version of semaglutide, which is used for managing weight and diabetes, thereby aiming to enhance the delivery and effectiveness of this treatment. - Anti-Nausea Formulations:
This category includes sublingual products designed to alleviate nausea, providing a more rapid relief option for patients experiencing this discomfort. - Anti-Psychotic Products:
Products aimed at managing mental health conditions will be formulated for sublingual delivery, allowing for swift action and patient compliance. - ED Drugs:
Sublingual formulations for erectile dysfunction medications are being explored, which could offer quicker onset of action compared to conventional delivery systems. - Seizure Medication:
Aspire is developing sublingual options for seizure medications, aiming to provide faster and more effective treatment during seizure events. - Caffeine Products:
The company is also looking into sublingual formulas for caffeine, including a single-dose pre-workout supplement that provides a rapid boost of energy and alertness.
Contact Information
Address: 23150 Fashion Drive
Phone: 415 592 7399
Website: https://aspirebiolabs.com
